US Stock MarketDetailed Quotes

CYTHW CYCLO THERAPEUTICS INC C/WTS 14/11/2025(TO PUR COM)

Watchlist
  • 0.2100
  • 0.00000.00%
Close Jun 14 16:00 ET
0Market Cap0.00P/E (TTM)

About CYCLO THERAPEUTICS INC C/WTS 14/11/2025(TO PUR COM) Company

Cyclo Therapeutics, Inc. engages in the development of cyclodextrin-based biopharmaceuticals for the treatment of disease. Its product pipeline include Trappsol Cyclo, which treats Neimann-Pick Type C disease and Alzheimer's disease. The company was founded by Charles E. Rick Strattan on August 9, 1990 and is headquartered in Gainesville, FL.

Company Profile

SymbolCYTHW
Company NameCYCLO THERAPEUTICS INC C/WTS 14/11/2025(TO PUR COM)
Listing DateDec 9, 2020
Founded1990
CEOMr. N. Scott Fine
MarketNASDAQ
Employees8
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address6714 NW 16th Street,Suite B
CityGainesville
ProvinceFlorida
CountryUnited States of America
Zip Code32653
Phone1-386-418-8060
Websitehttp://www.cyclotherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • N. Scott Fine
  • Director and Chief Executive Officer
  • 1.06M
  • Dr. Jeffrey L. Tate, PhD
  • Director and Chief Operating Officer
  • --
  • Michael Lisjak
  • Chief Regulatory Officer and Senior Vice President, Business Development
  • 582.70K
  • Joshua M. Fine
  • Chief Financial Officer, Principal Accounting Officer and Secretary
  • 586.18K
  • F. Patrick Ostronic
  • Vice Chairman of the Board
  • 55.00K
  • Markus W. Sieger
  • Chairman of the Board
  • 88.50K
  • C.E. Rick Strattan
  • Independent Director
  • 44.00K
  • Dr. Randall M. Toig
  • Independent Director
  • 47.50K
  • William Conkling
  • Independent Director
  • --
  • Shawn Cross
  • Independent Director
  • --
  • Dr. Vivien Wong, PhD
  • Independent Director
  • --
  • William S. Shanahan
  • Independent Director
  • 53.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg